Colorectal cancer (CRC) is presently one of the most common causes of cancer‐related
death in our setting and affects a great number of people each year. Screening strategies …

Since colorectal cancer is one of the world's most common cancers, studies on its prevention
and early diagnosis are an emerging area of clinical oncology these days. For this study, a …

In the third millennium preventive medicine is becoming a corner stone in our concept of
health. Colorectal cancer (CRC) prevention, in particular, has become an important goal for …

Chemoprevention began to be considered as a potential strategy for lowering the incidence
of cancer and cancer‐related deaths in the 1970s. For clinical chemoprevention trials …

Recent research has drawn attention to protective effects of chemopreventive agents that
reverse, suppress, or prevent the carcinogenic progression using pharmacological or …

Objective Novel treatments for colorectal cancer (CRC) include chemoprevention.
Nonsteroidal anti‐inflammatory drugs (NSAIDs) were the first to be studied and an inverse …

Chemopreventive strategies for colorectal cancer (CRC) have been extensively studied to
prevent the recurrence of adenomas and/or delay their development in the gastrointestinal …

Chemoprevention means the use of agents to prevent, delay, or reverse carcinogenesis.
This review was designed to critically discuss the most promising agents in colorectal cancer …

The treatment of colorectal cancer continues to improve, but it still remains the second
leading cause of cancer-related death in the United States. In 2001, there will be over …

Cancer is predicted to become the leading cause of death–surpassing heart disease–by the
end of this decade. Colorectal cancer is a major health concern, with more than 1,000,000 …